98%
921
2 minutes
20
Introduction: Results from prior studies show contradictory evidence in determining whether utilization of renal ischemia during partial nephrectomies (PN) results in worse renal functional outcomes. Data assessing a large cohort of patients with no ischemia PN are lacking. The purpose of this study was to evaluate whether the use and type of renal ischemia during PN affects renal functional outcomes.
Methods: A retrospective review of 742 patients undergoing PN was assessed and split into 4 cohorts: no ischemia (n = 455), cold ischemia (n = 63), warm ischemia time (WIT) ≤ 30 minutes (n = 164), and WIT > 30 minutes (n = 60). Twelve-month relative glomerular filtration rate (GFR) changes and split function were assessed among the cohorts. Univariate and multivariable regression analyses were used to determine predictors of postoperative acute kidney injury and long-term renal functional outcomes.
Results: No difference in the mean relative decrease in GFR was noted among the 4 cohorts at either the 3-month (8.7% ± 25.5%, = .1) or 12-month (7.5% ± 19.0%, = .2) period. On multivariable analysis, age (coefficient [coef]: 0.3, < .001), estimated blood loss (coef: 0.2 per 100 mL, = .02), baseline GFR (coef: 2 per 10 units, < .001), number of tumors resected (coef: 0.4, = .02), and postoperative acute kidney injury (coef: 8.3, < .001) were predictive of a higher percentage decrease in 12-month GFR while male sex (coef: -6.3, = .001) was inversely related. The type of ischemia or length of WIT was not associated with 12-month GFR change.
Conclusions: In patients undergoing PN, the use of and type of ischemia affects short-term but not long-term renal functional outcomes. Facility with multiple ischemia techniques may be useful in the management of patients requiring complex PN.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12018140 | PMC |
http://dx.doi.org/10.1097/UPJ.0000000000000779 | DOI Listing |
Pediatr Transplant
November 2025
Division of Urology, University of Toronto, Toronto, Canada.
Introduction: Differentiating acute tubular necrosis (ATN) from rejection in pediatric kidney transplant (KT) recipients remains challenging and necessitates invasive biopsy. Doppler ultrasound-derived resistive index (RI) is a noninvasive modality to assess graft status, but its diagnostic utility in children is unclear. This study evaluates RI's ability to distinguish ATN and rejection in KT.
View Article and Find Full Text PDFEur J Case Rep Intern Med
August 2025
Nephrology Department, Unidade Local de Saúde de Braga, Braga, Portugal.
Introduction: Bevacizumab is a monoclonal antibody that targets vascular endothelial growth factor (VEGF) and is widely used in oncology for its anti-angiogenic properties. However, VEGF inhibition may result in significant nephrotoxicity, including thrombotic microangiopathy (TMA). While systemic TMA is well-described, isolated renal-limited TMA remains under recognised.
View Article and Find Full Text PDFExp Ther Med
November 2025
School of Basic Medical Sciences, Binzhou Medical University, Yantai, Shandong 264003, P.R. China.
Acute kidney injury (AKI) is a group of common clinical syndromes characterized by a rapid decline in renal function over a short period of time. At present, the treatment methods are limited, and research is needed to identify drugs that could alleviate renal ischemia-reperfusion (I/R) injury. Tetramethylpyrazine (TMP) is a bioactive alkaloid extracted from the Chinese herbal medicine Chuanxiong.
View Article and Find Full Text PDFClin Kidney J
September 2025
Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy.
Genome editing technologies, particularly clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9, have transformed biomedical research by enabling precise genetic modifications. Due to its efficiency, cost-effectiveness and versatility, CRISPR has been widely applied across various stages of research, from fundamental biological investigations in preclinical models to potential therapeutic interventions. In nephrology, CRISPR represents a groundbreaking tool for elucidating the molecular mechanisms underlying kidney diseases and developing innovative therapeutic approaches.
View Article and Find Full Text PDFClin Kidney J
September 2025
Hypertension is a pervasive and progressive complication in chronic kidney disease (CKD) patients, affecting up to 90% of those in advanced stages or on dialysis. A particularly insidious aspect of this condition is nocturnal hypertension, characterized by high blood pressure (BP) during sleep and a blunted or absent nighttime BP dipping-phenomena associated with accelerated CKD progression and increased cardiovascular risk. Despite its strong prognostic significance, nocturnal hypertension remains underdiagnosed due to limited use of ambulatory BP monitoring.
View Article and Find Full Text PDF